Search research articles
Contact Us
Filters
Showing results (161-170 of 202) with videos related to
Page
of 21
Sort By:
Platelets
|
June 7, 2024
Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia
Veronika Dill, Kilian Kirmes, Jiaying Han, et al.
Translational Lung Cancer Research
|
December 13, 2024
Prognostic impact of targetable driver alterations in resected early-stage lung cancer
Angelika Terbuch, Selma Konjic, Verena Schlintl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update
Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, et al.
Leukemia
|
June 1, 2020
Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study
Carl C Crodel, Kathleen Jentsch-Ullrich, Steffen Koschmieder, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 13, 2023
Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models
Maria A Smolle, Dimosthenis Andreou, Judith Wölfel, et al.
Molecular Cell
|
May 22, 2012
The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity
Rune Busk Damgaard, Ueli Nachbur, Monica Yabal, et al.
Cancer Cell
|
July 15, 2016
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
Ulrike Höckendorf, Monica Yabal, Tobias Herold, et al.
Leukemia
|
July 12, 2020
Correction: Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study
Carl C Crodel, Kathleen Jentsch-Ullrich, Steffen Koschmieder, et al.
Science Advances
|
January 21, 2026
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression
Deepti Agrawal, Katarina Cisarova, Sebastian Vosberg, et al.
Blood Advances
|
December 1, 2022
Elevated RIPK3 correlates with disease burden in myelofibrosis
Veronika Dill, Celina V Wagner, Eva C Keller, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 202) with videos related to
Sort By:
Page
of 21
Platelets
|
June 7, 2024
Platelet mass cytometry reveals dysregulation of prothrombotic pathways in essential thrombocythemia
Veronika Dill, Kilian Kirmes, Jiaying Han, et al.
Translational Lung Cancer Research
|
December 13, 2024
Prognostic impact of targetable driver alterations in resected early-stage lung cancer
Angelika Terbuch, Selma Konjic, Verena Schlintl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 29, 2024
Sustained Clinical Benefit and Intracranial Activity of Tarlatamab in Previously Treated Small Cell Lung Cancer: DeLLphi-300 Trial Update
Afshin Dowlati, Horst-Dieter Hummel, Stephane Champiat, et al.
Leukemia
|
June 1, 2020
Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study
Carl C Crodel, Kathleen Jentsch-Ullrich, Steffen Koschmieder, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 13, 2023
Effect of radiotherapy on local recurrence, distant metastasis and overall survival in 1200 extremity soft tissue sarcoma patients. Retrospective analysis using IPTW-adjusted models
Maria A Smolle, Dimosthenis Andreou, Judith Wölfel, et al.
Molecular Cell
|
May 22, 2012
The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunity
Rune Busk Damgaard, Ueli Nachbur, Monica Yabal, et al.
Cancer Cell
|
July 15, 2016
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
Ulrike Höckendorf, Monica Yabal, Tobias Herold, et al.
Leukemia
|
July 12, 2020
Correction: Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study
Carl C Crodel, Kathleen Jentsch-Ullrich, Steffen Koschmieder, et al.
Science Advances
|
January 21, 2026
Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression
Deepti Agrawal, Katarina Cisarova, Sebastian Vosberg, et al.
Blood Advances
|
December 1, 2022
Elevated RIPK3 correlates with disease burden in myelofibrosis
Veronika Dill, Celina V Wagner, Eva C Keller, et al.
Page
of 21